
Urelumab ELISA Kit
Kwaliteit
ISO Gecertificeerd
Levering
24-48 uur
Technische Specificaties
Urelumab is a fully humanized agonistic monoclonal antibody targeting the CD137 receptor with potential immunostimulatory and antineoplastic activities. Urelumab specifically binds to and activates CD137-expressing immune cells, stimulating an immune response, in particular a cytotoxic T cell response, against tumor cells. Urelumab has been used in trials studying the treatment of Leukemia, Multiple Myeloma, Malignant Tumors, and Cancer-Solid Tumors and B-Cell Non-Hodgkin's Lymphoma. The antibody product was developed using Medarex's UltiMAb (R) technology and was the first UltiMAb-derived antibody in clinical development by Bristol-Myers Squibb under the December 2003 agreement with Medarex. In December 2008, enrolment was stopped for all urelumab studies following the occurrence of two hepatotoxicity-related deaths. Several years later, the clinical study on Urelumab was restarted. At present, the approval of the monoclonal antibody has not been disclosed in the relevant drug approval agency.
PRINCIPLE OF THE ASSAY This assay employs the quantitative indirect enzyme immunoassay technique. Recombinant Human CD137 has been pre-coated onto a microplate. Standards or samples are pipetted into the wells and any Urelumab present is bound by the immobilized protein. After washing away any unbound substances, a biotin-labeled Mouse Anti-Human IgG antibody is added to the wells. After washing away any unbound substances, Streptavidin-HRP is added to the wells. Following a wash to remove any unbound enzyme reagent, a substrate solution is added to the wells and color develops in proportion to the amount of Urelumab bound in the initial step. The color development is stopped and the intensity of the color is measured.
Urelumab
BMS-663513, CAS: 934823-49-1
Colorimetric
Quantitative
Plasma, Serum
31.25 - 2,000 ng/mL
80-120%
18.73 ng/mL
2-8 °C
When the kit was stored at the recommended temperature for 6 months, the signal intensity decreased by less than 20%. For unopened kits, if you want to prolong the storage time, please store the Standard, Detection A, Detection B and Microplate at - 20°C, the rest reagents should be store at 4°C.
For Research Use Only.
Beschrijving
PRINCIPLE OF THE ASSAY This assay employs the quantitative indirect enzyme immunoassay technique. Recombinant Human CD137 has been pre-coated onto a microplate.
Specificaties
Recent bekeken producten

Optical EtBr filter, 610 nm for SmartView Pro Imager System, 1100 & 2100 series (for UV)
UVCI-1100-EB
1 Unit

AGPAT4 Antibody
MBS7124622-01
0.05 mL

H&E Mount, Permanent Mountindg media for coverslipping H&E stains from water,
NB315
125 mL

SCD polyclonal antibody
GTR18043932-01
50 μL

(KO Validated) SUMO1 Polyclonal Antibody
E-AB-92410-01
60 µL

Salicylate hydroxylase, Microorganism
HY-E70520-01
1 KU

Purified Diphtheria Toxoid protein (cGMP/USP, vaccine grade, ~1500-2500 Lf/ml; Low endotoxin)
DTOX16-N-500
500 µg

BioCoupler® Glass Set (16 oz) x12
BCS1612
12 Each
Recent gezochte producten

Total BDNF Quantikine ELISA Kit
DBNT00
96 Tests

Quantikine Immunoassay Control Set 885 for Total BDNF
QC218
1 Set

Total BDNF Quantikine SixPak (6 Plates)
SBNT00
6x 96 Tests

Rabbit Polyclonal BDNF Antibody
NB100-98682SS
0.025 mL

Polyclonal BDNF Antibody (CT)
APG02267G
0.1ml

Polyclonal BDNF Antibody
APG02253G
0.05mg

Polyclonal BDNF Antibody
APG02256G
0.1mg

Polyclonal BDNF Antibody
APG02257G
0.05ml
